Seltenheiten beim Mammakarzinom - Teil 2

Phylloidestumoren und Brustangiosarkome gehören zu den seltensten bösartigen Tumoren der Mamma und stellen eine diagnostische und therapeutische Herausforderung im klinischen Alltag dar. Dieser Übersichtsartikel bietet eine umfangreiche Darstellung der Datenlage hinsichtlich Epidemiologie, Pathogenese, Diagnostik, Therapie und Prognose, um die Versorgung betroffener Patientinnen zu verbessern.

Schlüsselwörter

Phylloidestumor - Angiosarkom - RAAS - Brusttumore

• Literatur

• 1 Lissidini G, Mule A, Santoro A. et al. Malignant phyllodes tumor of the breast: a systematic review. Pathologica 2022; 114: 111-120
• 2 Yu CY, Huang TW, Tam KW. Management of phyllodes tumor: A systematic review and meta-analysis of real-world evidence. Int J Surg 2022; 107: 106969
• 3 Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer 1993; 71: 3020-3024
• 4 Tan BY, Acs G, Apple SK. et al. Phyllodes tumours of the breast: a consensus review. Histopathology 2016; 68: 5-21
• 5 Ofri A, Stuart KE, Chan B. et al. Diagnosis and management of phyllodes tumours for the surgeon: An algorithm. Surgeon 2022; 20: e355-e365
• 6 Lu Y, Chen Y, Zhu L. et al. Local Recurrence of Benign, Borderline, and Malignant Phyllodes Tumors of the Breast: A Systematic Review and Meta-analysis. Ann Surg Oncol 2019; 26: 1263-1275
• 7 Zhang Y, Kleer CG. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates. Arch Pathol Lab Med 2016; 140: 665-671
• 8 Kommission Mamma der Arbeitsgemeinschaft Gynäkologische Onkologie e. V. Diagnostik und Therapie früher und fortgeschrittener Mammakarzinome. Accessed November 02, 2025 at: https://www.ago-online.de/fileadmin/ago-online/downloads/_leitlinien/kommission_mamma/2025/AGO_2025D_Gesamtdatei.pdf
• 9 Tan PH, Thike AA, Tan WJ. et al. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol 2012; 65: 69-76
• 10 Choi J, Koo JS. Comparative study of histological features between core needle biopsy and surgical excision in phyllodes tumor. Pathol Int 2012; 62: 120-126
• 11 Khazai L, Middleton LP, Goktepe N. et al. Breast pathology second review identifies clinically significant discrepancies in over 10% of patients. J Surg Oncol 2015; 111: 192-197
• 12 Tan PH. Refining the classification of breast phyllodes tumours. Pathology 2023; 55: 437-448
• 13 Refai F. Prognostic value of Ki67 in phyllodes tumor of the breast: A systematic review and meta‑analysis. Exp Ther Med 2024; 28: 457
• 14 Otsuji K, Sasaki T, Tanabe M. et al. Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations. Br J Cancer 2021; 124: 466-473
• 15 Md Nasir ND, Ng CCY, Rajasegaran V. et al. Genomic characterisation of breast fibroepithelial lesions in an international cohort. J Pathol 2019; 249: 447-460
• 16 Bansal R, Adeyelu T, Elliott A. et al. Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy. JCO Precis Oncol 2024; 8: e2400289
• 17 Duman L, Gezer NS, Balci P. et al. Differentiation between Phyllodes Tumors and Fibroadenomas Based on Mammographic Sonographic and MRI Features. Breast Care (Basel) 2016; 11: 123-127
• 18 Kamitani T, Matsuo Y, Yabuuchi H. et al. Differentiation between benign phyllodes tumors and fibroadenomas of the breast on MR imaging. Eur J Radiol 2014; 83: 1344-1349
• 19 McCarthy E, Kavanagh J, O’Donoghue Y. et al. Phyllodes tumours of the breast: radiological presentation, management and follow-up. Br J Radiol 2014; 87: 20140239
• 20 Belkacemi Y, Bousquet G, Marsiglia H. et al. Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys 2008; 70: 492-500
• 21 Gnerlich JL, Williams RT, Yao K. et al. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009. Ann Surg Oncol 2014; 21: 1222-1230
• 22 Fede ABS, Pereira Souza R, Doi M. et al. Malignant Phyllodes Tumor of the Breast: A Practice Review. Clin Pract 2021; 11: 205-215
• 23 Morales-Vasquez F, Gonzalez-Angulo AM, Broglio K. et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast. Breast J 2007; 13: 551-556
• 24 Goodwin B, Oyinlola AF, Palhang M. et al. Metastatic and Malignant Phyllodes Tumors of the Breast: An Update for Current Management. Am Surg 2023; 89: 6190-6196
• 25 Bonito FJP, de Almeida Cerejeira D, Dahlstedt-Ferreira C. et al. Radiation-induced angiosarcoma of the breast: A review. Breast J 2020; 26: 458-463
• 26 An R, Men XJ, Ni XH. et al. Angiosarcoma of the breast: A review. Heliyon 2024; 10: e24413
• 27 Esperanca-Martins M, Melo-Alvim C, Damaso S. et al. Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities. Cancers (Basel) 2023; 15: 3933
• 28 Conti M, Morciano F, Rossati C. et al. Angiosarcoma of the Breast: Overview of Current Data and Multimodal Imaging Findings. J Imaging 2023; 9: 94
• 29 Veiga LHS, Vo JB, Curtis RE. et al. Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study. Lancet Oncol 2022; 23: 1451-1464
• 30 Zhu Y, Nakamoto S, Tsukioki T. et al. Primary angiosarcoma of the breast: a literature review. Chin Clin Oncol 2024; 13: 68
• 31 Gutkin PM, Ganjoo KN, Lohman M. et al. Angiosarcoma of the Breast: Management and Outcomes. Am J Clin Oncol 2020; 43: 820-825
• 32 Cozzi S, Finocchi Ghersi S, Tava F. et al. Radiation-Associated Angiosarcoma of the Breast: The State of the Art of a Rare and Aggressive Disease. J Pers Med 2024; 14: 859
• 33 Vogt T, Muller CSL, Melchior P. et al. S1-Leitlinie kutane Angiosarkome – Update 2021. J Dtsch Dermatol Ges 2021; 19: 1801-1813
• 34 Donnell RM, Rosen PP, Lieberman PH. et al. Angiosarcoma and other vascular tumors of the breast. Am J Surg Pathol 1981; 5: 629-642
• 35 Sher T, Hennessy BT, Valero V. et al. Primary angiosarcomas of the breast. Cancer 2007; 110: 173-178
• 36 McKay KM, Doyle LA, Lazar AJ. et al. Expression of ERG, an Ets family transcription factor, distinguishes cutaneous angiosarcoma from histological mimics. Histopathology 2012; 61: 989-991
• 37 Glazebrook KN, Magut MJ, Reynolds C. Angiosarcoma of the breast. AJR Am J Roentgenol 2008; 190: 533-538
• 38 O’Neill AC, D’Arcy C, McDermott E. et al. Magnetic resonance imaging appearances in primary and secondary angiosarcoma of the breast. J Med Imaging Radiat Oncol 2014; 58: 208-212
• 39 Jallali N, James S, Searle A. et al. Surgical management of radiation-induced angiosarcoma after breast conservation therapy. Am J Surg 2012; 203: 156-161
• 40 Degnim AC, Siontis BL, Ahmed SK. et al. Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast. Clin Cancer Res 2023; 29: 2885-2893
• 41 Young RJ, Brown NJ, Reed MW. et al. Angiosarcoma. Lancet Oncol 2010; 11: 983-991
• 42 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF). S3-Leitlinie Adulte Weichgewebesarkome, Langversion 1.1, AWMF-Registernummer: 032/044OL. 2022 Accessed October 05, 2025 at: https://register.awmf.org/de/leitlinien/detail/032-044OL